Drug Trial Radar · NCT07094516
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
96
Actual
Start
Aug 7, 2025
Primary completion
Sep 14, 2028
Study completion Dec 31, 2030
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Jul 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD followed by an Extension. The double-blind part is 72 weeks long, followed by an extension.
Conditions
- Alzheimer's Disease
Interventions
VHB937Biological
VHB937 solution for infusion
VHB937Biological
VHB937 solution for infusion
PlaceboOther
Solution for infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in the Clinical Dementia Rating scale - Sum of Boxes (CDR-SB)Time frame: Baseline and Week 72
Locations
73 sites in 15 countries. Site status is shown where the registry gives one.
Banner Alzheimers Institute
Phoenix, Arizona
Irvine Center for Clinical Research
Irvine, California
University of California San Diego
La Jolla, California
University of California at Los Angeles
Los Angeles, California
Jem Research Institute
Atlantis, Florida
Visionary Investigators Network
Aventura, Florida
K2 Medical Research LLC
Maitland, Florida
Renstar Medical Research
Ocala, Florida
Charter Research The Villages
The Villages, Florida
Alzheimers Research Treatment Ctr
Wellington, Florida
Conquest Research
Winter Park, Florida
Hawaii Pacific Neuroscience LLC
Honolulu, Hawaii
University of Kansas Hospital
Fairway, Kansas
ActivMed Practices and Research
Methuen, Massachusetts
Citizens Memorial Hospital Neurology CLinic
Bolivar, Missouri
Lou Ruvo Center for Brain Health
Las Vegas, Nevada
UNC Hosp Invest Drug Serv Pharm
Chapel Hill, North Carolina
The Ohio State University
Columbus, Ohio
Neural Net Research
Portland, Oregon
Abington Neurological Associates Ltd
Willow Grove, Pennsylvania
University of Texas Health Science Center at San Antonio
San Antonio, Texas
University of Washington Medical Center
Seattle, Washington
Novartis Investigative Site
Camperdown, New South Wales, Australia
Novartis Investigative Site
Kogarah, New South Wales, Australia
Novartis Investigative Site
Box Hill, Victoria, Australia
Novartis Investigative Site
Heidelberg, Victoria, Australia
Novartis Investigative Site
Nedlands, Western Australia, Australia
Novartis Investigative Site
London, Ontario, Canada
Novartis Investigative Site
North York, Ontario, Canada
Novartis Investigative Site
Ottawa, Ontario, Canada
Novartis Investigative Site
Toronto, Ontario, Canada
Novartis Investigative Site
Toronto, Ontario, Canada
Novartis Investigative Site
Shanghai, China
Novartis Investigative Site
Hangzhou, Zhejiang, China
Novartis Investigative Site
Brno, Czechia
Novartis Investigative Site
Prague, Czechia
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Toulouse, Haute Garonne, France
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
München, Germany
Showing 40 of 73 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.